JP2004517853A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004517853A5 JP2004517853A5 JP2002554050A JP2002554050A JP2004517853A5 JP 2004517853 A5 JP2004517853 A5 JP 2004517853A5 JP 2002554050 A JP2002554050 A JP 2002554050A JP 2002554050 A JP2002554050 A JP 2002554050A JP 2004517853 A5 JP2004517853 A5 JP 2004517853A5
- Authority
- JP
- Japan
- Prior art keywords
- phenyl
- methyl
- methylsulfonyl
- pharmaceutical composition
- pharmaceutically acceptable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US25944101P | 2001-01-03 | 2001-01-03 | |
| PCT/US2001/049638 WO2002053099A2 (en) | 2001-01-03 | 2001-12-28 | Methods and compositions for treating periodontal disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2004517853A JP2004517853A (ja) | 2004-06-17 |
| JP2004517853A5 true JP2004517853A5 (https=) | 2005-12-22 |
Family
ID=22984959
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002554050A Withdrawn JP2004517853A (ja) | 2001-01-03 | 2001-12-28 | 歯周病の治療方法及び治療用組成物 |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP1349548A4 (https=) |
| JP (1) | JP2004517853A (https=) |
| AU (1) | AU2002246757B2 (https=) |
| CA (1) | CA2432504A1 (https=) |
| WO (1) | WO2002053099A2 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201305668D0 (en) | 2013-03-28 | 2013-05-15 | Glaxosmithkline Ip Dev Ltd | Avs6 Integrin Antagonists |
| PL3050878T3 (pl) | 2013-09-24 | 2022-01-24 | Fujifilm Corporation | Zawierający atom azotu związek lub jego sól, lub ich kompleks z metalem |
| GB201417011D0 (en) | 2014-09-26 | 2014-11-12 | Glaxosmithkline Ip Dev Ltd | Novel compounds |
| GB201417094D0 (en) | 2014-09-26 | 2014-11-12 | Glaxosmithkline Ip Dev Ltd | Novel compounds |
| GB201417002D0 (en) | 2014-09-26 | 2014-11-12 | Glaxosmithkline Ip Dev Ltd | Novel compound |
| GB201417018D0 (en) | 2014-09-26 | 2014-11-12 | Glaxosmithkline Ip Dev Ltd | Novel compounds |
| GB201604680D0 (en) | 2016-03-21 | 2016-05-04 | Glaxosmithkline Ip Dev Ltd | Chemical Compounds |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5190981A (en) * | 1989-08-17 | 1993-03-02 | Sepracor Inc. | Formulation containing S(+) enantiomer of flurbiprofen or ketoprofen and method of use for oral administration for prevention and treatment of bone loss associated with periodontal disease |
| US20020028798A1 (en) * | 1995-12-12 | 2002-03-07 | Omeros Medical Systems | Irrigation solution and method for inhibition of pain and inflammation |
| US6048861A (en) * | 1997-12-17 | 2000-04-11 | Merck & Co., Inc. | Integrin receptor antagonists |
| TR200001752T2 (tr) * | 1997-12-17 | 2000-12-21 | Merck & Co., Inc. | Entegrin reseptör antagonistleri |
| US6017926A (en) * | 1997-12-17 | 2000-01-25 | Merck & Co., Inc. | Integrin receptor antagonists |
| US6136804A (en) * | 1998-03-13 | 2000-10-24 | Merck & Co., Inc. | Combination therapy for treating, preventing, or reducing the risks associated with acute coronary ischemic syndrome and related conditions |
| AU747784B2 (en) * | 1998-07-29 | 2002-05-23 | Merck & Co., Inc. | Integrin receptor antagonists |
| PT1187592E (pt) * | 1999-06-02 | 2007-10-19 | Merck & Co Inc | Antagonistas dos receptores de integrina alfa v |
-
2001
- 2001-12-28 JP JP2002554050A patent/JP2004517853A/ja not_active Withdrawn
- 2001-12-28 EP EP01994350A patent/EP1349548A4/en not_active Ceased
- 2001-12-28 AU AU2002246757A patent/AU2002246757B2/en not_active Ceased
- 2001-12-28 WO PCT/US2001/049638 patent/WO2002053099A2/en not_active Ceased
- 2001-12-28 CA CA002432504A patent/CA2432504A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2014372166B2 (en) | Pharmaceutical combinations | |
| US20140343084A1 (en) | Imidazopyrrolidinone compounds | |
| JP2020516671A5 (https=) | ||
| JP2007519649A5 (https=) | ||
| CA2345641A1 (en) | A method for treating inflammatory diseases by administering a thrombin inhibitor | |
| JP2003528872A5 (https=) | ||
| JP2018511626A5 (https=) | ||
| JP2003513961A (ja) | シクロオキシゲナーゼ−２の阻害剤である５−アリール−１ｈ−１，２，４−トリアゾール化合物とそれを含む医薬品組成物 | |
| JP2008523041A5 (https=) | ||
| IL205501A (en) | Preparation of preparations for the treatment of arthritis | |
| JP2013531070A5 (https=) | ||
| EA034872B1 (ru) | Комбинация ингибитора mek кобиметиниба и ингибитора erk (s)-1-(1-(4-хлор-3-фторфенил)-2-гидроксиэтил)-4-(2-((1-метил-1h-пиразол-5-ил)амино)пиримидин-4-ил)пиридин-2(1h)-она для применения в лечении раковых заболеваний | |
| RU2003112610A (ru) | Производные пиразола для лечения вирксных заболеваний | |
| US20020016342A1 (en) | Combination therapy using COX-2 selective inhibitor and thromboxane inhibitor and compositions therefor | |
| JP2009501775A5 (https=) | ||
| JP2004517853A5 (https=) | ||
| JP2012517441A5 (https=) | ||
| JP2004524279A5 (https=) | ||
| MXPA05005510A (es) | Administracion dermica de un inhibidor selectivo de la ciclooxigenasa-2, soluble en agua, por ejemplo, parecoxib y valdecoxib. | |
| WO2001056555A2 (en) | Use of cox-2 inhibitors for the treatment of constipation | |
| NL1024830C2 (nl) | Dermale aflevering van een wateroplosbare selectieve cyclooxygenase-2-remmer. | |
| JP2011524362A5 (https=) | ||
| JP2016501254A5 (https=) | ||
| US20020040039A1 (en) | Treatment of inflammation with a combination of a cyclooxygenase-2 inhibitor and an integrin alpha-v antagonist | |
| WO2012052180A1 (en) | Combinations comprising dhodh inhibitors and cox inhibitors |